A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members

Revision Bulletin

Oxybutynin Chloride Tablets

Posting Date: 30 October 2009; updated 26 February 2010
Official Date: 1 December 2009
Expert Committee: Biopharmaceutics


In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the monograph to include an accepted dissolution test 2 with different dissolution conditions approved by the U.S. Food and Drug Administration.

The Oxybutynin Chloride Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated into the First Supplement to the USP 33-NF 28 Reissue.

Should you have any questions, please contact Margareth Marques, Ph.D., (301–816–8106 or ).

Download the Oxybutynin Chloride Tablets Revision Bulletin  (108KB)